EMEA-001931-PIP02-19
Key facts
| Active substance |
human fibrinogen
|
| Therapeutic area |
Haematology-Hemostaseology
|
| Decision number |
P/0352/2019
|
| PIP number |
EMEA-001931-PIP02-19
|
| Pharmaceutical form(s) |
Powder for solution for injection or infusion
|
| Condition(s) / indication(s) |
Treatment of acquired fibrinogen deficiency
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Biotest AG
Tel. + 49 6103 801497 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions/indications
|